Valuation (62%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 1.29 | N/A |
PEG Ratio (TTM) | -0.05 | N/A |
P/S Ratio (TTM) | 0.28 | N/A |
P/B Ratio (TTM) | 1.04 | N/A |
P/FCF Ratio (TTM) | 31.82 | N/A |
Price to 5YR AVG Earnings Ratio | 0.58 | N/A |
Price to 5YR AVG FCF Ratio | -0.40 | N/A |
Profitability (70%) |
Company | Industry |
---|---|---|
ROA (TTM) | 20.40% | N/A |
ROE (TTM) | 103.09% | N/A |
Net Profit Margin (TTM) | 21.45% | N/A |
ROIC 5YR AVG | -4.63% | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -34.06% | 66.97% | 77.74% |
Revenue | -1.57% | 8.46% | 2.20% |
Net Income | -6.99% | 66.20% | 78.42% |
Cash Flow | -20.09% | -142.91% | -37.45% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.09 | N/A |
Quick Ratio (TTM) | 1.09 | N/A |
D/E Ratio (TTM) | 0.21 | N/A |
Interest Coverage (TTM) | 59.64 | N/A |
Piotroski F-Score | 6 | N/A |
Altman Z-Score | 0.50 | N/A |
LTL to 5YR AVG FCF | -1.32 | N/A |
Shares Outstanding Growth 5YR AVG | 1.91% | N/A |